Benefits and harms of drug treatments

British Medical Journal

Volumn 329, Issue 7456, 2004, Pages 2-3

  Vandenbroucke, Jan P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CLINICAL TRIAL; DRUG INFORMATION; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 3042720645     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7456.2     Document Type: Editorial

References (11)

1. Cuervo LG, Clarke M. Balancing benefits and harms in health care. BMJ 2003;327:65-6.
2. Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. BMJ 2004;328:39-41.
3. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004;363:1728-31.
4. Sackett DL, Wennberg JE. Choosing the best research design for each question. BMJ 1997;315:1636.
5. Jick H. The discovery of drug-induced illness. N Engl J Med 1977;296:481-5.
6. Loke YK, Derry S. Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol 2001;1:3.
7. McPherson K, Hemminki E. Synthesising licensing data to assess drug safety. BMJ 2004;328:518-20.
8. Grant A, Chalmers I. Some research strategies for investigating aetiology and assessing the effects of clinical practice. In: Macdonald RR, ed. Scientific basis of obstetrics and gynaecology. 3rd ed. London: Churchill Livingstone, 1985:49-84.
9. Skegg DCG, Doll R. The case for recording events in clinical trials. BMJ 1977;ii:1523-4.
10. Vandenbroucke JP. Observational research and evidence-based medicine: What should we teach young physicians? J Clin Epidemiol 1998;51:467-72.
11. Loke VK, Derry S, Aronson JK. A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone. Br J Clin Pharmacol 2004;57:616-21.